Patients with cerebral infarction have abnormal sweating, which is a kind of plant nerve dysfunction caused by cerebral infarction itself, and can be treated with oral glutamatergic regulation of plant nerves, while cerebral infarction should be actively treated. For patients with ultra-early onset, such as within six hours, intravenous thrombolytic therapy can be given if thrombolysis is suitable. If more than six hours later, try to give aspirin to antiplatelet aggregation. At the same time, anticoagulation, fibrin-lowering and neuroprotective therapy can be given, as well as volume expansion therapy. If the patient has somatic signs and symptoms, routinely apply butylphthalide to improve the signs and symptoms of neurological deficits. If the patient has impaired consciousness, brain-awakening treatment should be given to wake up the brain. If the patient has increased intracranial pressure, the patient should be given cranial pressure-lowering treatment in a timely manner, and the commonly used drugs include mannitol, glycerol fructose and tachyphylaxis. If the patient’s blood pressure is low, the patient should be routinely treated with volume expansion, and the commonly used drugs are 706 plasma substitute. If the patient’s physical symptoms and signs are heavy, rehabilitation treatment should be given as soon as possible after 48-72 hours of stabilization.